Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer.

scientific article published on 16 September 2010

Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1872-034X.2010.00720.X
P8608Fatcat IDrelease_wlantpcct5e4pdojshf4i5a634
P698PubMed publication ID20849431

P50authorFumitaka SuzukiQ114923480
Masahiro KobayashiQ114923755
Yoshiyuki SuzukiQ114923935
Yasuji AraseQ114924322
Satoshi SaitoQ114924602
Tetsuya HosakaQ56223851
Norio AkutaQ87747459
Yusuke KawamuraQ90407021
Hitomi SezakiQ92198438
Kenji IkedaQ114433562
Hiromitsu KumadaQ114433568
P2093author name stringYuya Seko
Miharu Hirakawa
Norihiro Imai
P2860cites workEffects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinomaQ34225751
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virusQ44314372
Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trialQ45737388
P433issue12
P921main subjectHepatitis C virusQ708693
P304page(s)1168-1175
P577publication date2010-09-16
P1433published inHepatology ResearchQ15752035
P1476titleAdministration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
P478volume40

Reverse relations

cites work (P2860)
Q38134777A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma
Q45351713Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis
Q37972807Adjuvant therapy after curative treatment for hepatocellular carcinoma
Q34101953Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review
Q36436294Current status of multimodal & combination therapy for hepatocellular carcinoma
Q40051671Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Q50527907Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.

Search more.